Showing results (121-130 of 128) with videos related to
Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 128 results.
Journal of Neurosurgery|July 5, 2014
Phase I/IIa trial of fractionated radiotherapy, temozolomide, and autologous formalin-fixed tumor vaccine for newly diagnosed glioblastomaEiichi Ishikawa, Yoshihiro Muragaki, Tetsuya Yamamoto, et al.International Journal of Radiation Oncology, Biology, Physics|January 31, 2012
Evaluation of liver function after proton beam therapy for hepatocellular carcinomaMasashi Mizumoto, Toshiyuki Okumura, Takayuki Hashimoto, et al.International Journal of Radiation Oncology, Biology, Physics|October 5, 2010
Proton beam therapy for hepatocellular carcinoma: a comparison of three treatment protocolsMasashi Mizumoto, Toshiyuki Okumura, Takayuki Hashimoto, et al.Diabetes Research and Clinical Practice|October 31, 2012
The reliability and validity of the Japanese version of the Diabetes Family Behavior Checklist (DFBC) for assessing the relationship between type 2 diabetes mellitus patients and their families with respect to adherence to treatment regimenYoriko Hara, Sanae Iwashita, Kouzabu Ishii, et al.Radiation Oncology (London, England)|October 18, 2013
A phase I study on combined therapy with proton-beam radiotherapy and in situ tumor vaccination for locally advanced recurrent hepatocellular carcinomaMasato Abei, Toshiyuki Okumura, Kuniaki Fukuda, et al.Journal of Neurosurgery|May 17, 2011
Phase I/IIa trial of autologous formalin-fixed tumor vaccine concomitant with fractionated radiotherapy for newly diagnosed glioblastoma. Clinical articleYoshihiro Muragaki, Takashi Maruyama, Hiroshi Iseki, et al.Journal of Neurosurgery|January 21, 2023
A multicenter, randomized, placebo-controlled phase IIb trial of an autologous formalin-fixed tumor vaccine for newly diagnosed glioblastomasYoshihiro Muragaki, Eiichi Ishikawa, Takashi Maruyama, et al.Neuro-Oncology Practice|November 12, 2016
A prospective, multicentre, single-arm clinical trial of bevacizumab for patients with surgically untreatable, symptomatic brain radiation necrosis†Motomasa Furuse, Naosuke Nonoguchi, Toshihiko Kuroiwa, et al.Pageof 13